Literature DB >> 28549675

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis.

Zobair M Younossi1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28549675     DOI： 10.1016/j.cgh.2017.05.029

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  7 in total

1.  Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.

Authors:  Zobair M Younossi; Rohit Loomba; Quentin M Anstee; Mary E Rinella; Elisabetta Bugianesi; Giulio Marchesini; Brent A Neuschwander-Tetri; Lawrence Serfaty; Francesco Negro; Stephen H Caldwell; Vlad Ratziu; Kathleen E Corey; Scott L Friedman; Manal F Abdelmalek; Stephen A Harrison; Arun J Sanyal; Joel E Lavine; Philippe Mathurin; Michael R Charlton; Zachary D Goodman; Naga P Chalasani; Kris V Kowdley; Jacob George; Keith Lindor
Journal:  Hepatology       Date:  2018-07       Impact factor: 17.425

2.  Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in vivo and in vitro experiments.

Authors:  Zu-Yin Li; Gang Wu; Chen Qiu; Zhi-Jie Zhou; Yu-Peng Wang; Guo-He Song; Chao Xiao; Xin Zhang; Gui-Long Deng; Rui-Tao Wang; Yu-Long Yang; Xiao-Liang Wang
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

3.  Investigating the Association Between Seven Sleep Traits and Nonalcoholic Fatty Liver Disease: Observational and Mendelian Randomization Study.

Authors:  Hong Fan; Zhenqiu Liu; Xin Zhang; Huangbo Yuan; Xiaolan Zhao; Renjia Zhao; Tingting Shi; Sheng Wu; Yiyun Xu; Chen Suo; Xingdong Chen; Tiejun Zhang
Journal:  Front Genet       Date:  2022-05-17       Impact factor: 4.772

Review 4.  Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.

Authors:  Masato Yoneda; Kento Imajo; Hirokazu Takahashi; Yuji Ogawa; Yuichiro Eguchi; Yoshio Sumida; Masashi Yoneda; Miwa Kawanaka; Satoru Saito; Katsutoshi Tokushige; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2017-11-24       Impact factor: 7.527

Review 5.  Role of Natural Phenolics in Hepatoprotection: A Mechanistic Review and Analysis of Regulatory Network of Associated Genes.

Authors:  Priyanka Saha; Anupam Das Talukdar; Rajat Nath; Satyajit D Sarker; Lutfun Nahar; Jagajjit Sahu; Manabendra Dutta Choudhury
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

6.  Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD).

Authors:  Pegah Golabi; Maria Stepanova; Huong T Pham; Rebecca Cable; Nila Rafiq; Haley Bush; Trevor Gogoll; Zobair M Younossi
Journal:  BMJ Open Gastroenterol       Date:  2018-03-20

7.  Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality.

Authors:  Pegah Golabi; James Paik; Natsu Fukui; Cameron T Locklear; Leyla de Avilla; Zobair M Younossi
Journal:  Clin Diabetes       Date:  2019-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.